Amplify Weight Loss Drug & Treatment ETF THNR
25.92 USD +0.17 (+0.67%)
At closeNov 6, 2026, 4:04 PM EST
25.92 0.00 0.00%
After hours · Nov 6, 4:04 PM ET
25.66 Day range 25.92
23.48 52-week range 27.91
- YTD
- +2.76%
- 1 year
- +10.28%
News
etftrends.com Eli Lilly, Regeneron Lead Weight-Loss ETF THNR Higher The Amplify Weight Loss Drug & Treatment ETF (THNR) returned 3.2% in October, according to Amplify ETFs. Eli Lilly and Co. (LLY) drove most of that gain, after reporting quarterly results that beat…
etftrends.com What the Holidays Hold for GLP-1 Stocks in THNR The holiday season is almost here and will soon be followed by the annual surge in New Year's resolutions. This will likely drive renewed interest in GLP-1 products, especially as new oral GLP-1…
benzinga.com Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval Food makers and restaurants adjust menus and products as GLP-1 drugs drive demand for high-protein foods and smaller portions across the U.S.